Ruikun Du

1.4k total citations
54 papers, 1.0k citations indexed

About

Ruikun Du is a scholar working on Epidemiology, Molecular Biology and Immunology. According to data from OpenAlex, Ruikun Du has authored 54 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Epidemiology, 19 papers in Molecular Biology and 16 papers in Immunology. Recurrent topics in Ruikun Du's work include Influenza Virus Research Studies (23 papers), interferon and immune responses (14 papers) and Respiratory viral infections research (13 papers). Ruikun Du is often cited by papers focused on Influenza Virus Research Studies (23 papers), interferon and immune responses (14 papers) and Respiratory viral infections research (13 papers). Ruikun Du collaborates with scholars based in China, United States and Sweden. Ruikun Du's co-authors include Lijun Rong, Qinghua Cui, Miaomiao Liu, Yanyan Wang, Xiujuan Zhao, Laura Cooper, Han Cheng, Hyun Lee, Ping Li and Rong Rong and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Journal of Medicinal Chemistry.

In The Last Decade

Ruikun Du

52 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruikun Du China 18 368 326 237 170 143 54 1.0k
Qinghua Cui China 22 533 1.4× 316 1.0× 265 1.1× 196 1.2× 199 1.4× 52 1.3k
Jae-Hyoung Song South Korea 23 472 1.3× 279 0.9× 318 1.3× 287 1.7× 174 1.2× 64 1.4k
Shih‐Chao Lin United States 21 425 1.2× 120 0.4× 362 1.5× 124 0.7× 105 0.7× 53 1.3k
Jae Min Song South Korea 14 275 0.7× 391 1.2× 197 0.8× 227 1.3× 78 0.5× 24 1.2k
Hyung‐Jun Kwon South Korea 21 537 1.5× 123 0.4× 522 2.2× 125 0.7× 169 1.2× 59 1.5k
Runfeng Li China 16 392 1.1× 216 0.7× 509 2.1× 215 1.3× 87 0.6× 47 1.4k
Hovakim Zakaryan Armenia 16 238 0.6× 84 0.3× 260 1.1× 158 0.9× 141 1.0× 36 1.1k
Sing‐Sin Sam Malaysia 18 333 0.9× 124 0.4× 555 2.3× 117 0.7× 273 1.9× 39 1.7k
Adrian Oo United States 12 244 0.7× 73 0.2× 246 1.0× 96 0.6× 150 1.0× 27 922

Countries citing papers authored by Ruikun Du

Since Specialization
Citations

This map shows the geographic impact of Ruikun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruikun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruikun Du more than expected).

Fields of papers citing papers by Ruikun Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruikun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruikun Du. The network helps show where Ruikun Du may publish in the future.

Co-authorship network of co-authors of Ruikun Du

This figure shows the co-authorship network connecting the top 25 collaborators of Ruikun Du. A scholar is included among the top collaborators of Ruikun Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruikun Du. Ruikun Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Jing, Carolina Q. Sacramento, Ping Li, et al.. (2025). Antiviral effects and mechanism of Qi pi pill against influenza viruses. Animal Models and Experimental Medicine. 8(8). 1364–1375.
3.
Du, Ruikun, Jiawen Sun, Chunlei Zhang, et al.. (2025). Kaempferide enhances type I interferon signaling as a novel broad-spectrum antiviral agent. Antiviral Research. 237. 106141–106141. 2 indexed citations
4.
Gaisina, Irina N., Ping Li, Ruikun Du, et al.. (2024). An orally active entry inhibitor of influenza A viruses protects mice and synergizes with oseltamivir and baloxavir marboxil. Science Advances. 10(8). eadk9004–eadk9004. 10 indexed citations
5.
Liu, Miaomiao, et al.. (2024). Integrated serum pharmacochemistry and investigation of the anti-influenza A virus pneumonia effect of Qingjin Huatan decoction. Journal of Ethnopharmacology. 323. 117701–117701. 11 indexed citations
6.
Du, Ruikun, Laura Cooper, Ran Yan, et al.. (2023). Sulforaphane is a reversible covalent inhibitor of 3‐chymotrypsin‐like protease of SARS‐CoV‐2. Journal of Medical Virology. 95(3). e28609–e28609. 7 indexed citations
7.
Du, Ruikun, et al.. (2023). Influenza virus cell entry and targeted antiviral development. Journal of Medical Virology. 95(11). e29181–e29181. 7 indexed citations
8.
Li, Ping, Han Ju, Ying Zhang, et al.. (2023). Discovery of ligustrazine and chalcone derivatives as novel viral nucleoprotein nuclear export inhibitors against influenza viruses. Journal of Medical Virology. 95(7). e28968–e28968. 10 indexed citations
9.
Wang, Yanyan, et al.. (2023). Allopregnanolone targets nucleoprotein as a novel influenza virus inhibitor. Virologica Sinica. 38(6). 931–939. 4 indexed citations
10.
Zhang, Chengcheng, Guoying Zhang, Yu Zhang, et al.. (2022). Development of an HiBiT‐tagged reporter H3N2 influenza A virus and its utility as an antiviral screening platform. Journal of Medical Virology. 95(1). e28345–e28345. 11 indexed citations
11.
Du, Ruikun, Qinghua Cui, Michael Caffrey, & Lijun Rong. (2022). Ebola Virus Entry Inhibitors. Advances in experimental medicine and biology. 1366. 155–170. 3 indexed citations
12.
Du, Ruikun, et al.. (2022). Revisiting influenza A virus life cycle from a perspective of genome balance. Virologica Sinica. 38(1). 1–8. 22 indexed citations
13.
Ju, Han, N. Arul Murugan, Ping Li, et al.. (2021). Identification of C5-NH2 Modified Oseltamivir Derivatives as Novel Influenza Neuraminidase Inhibitors with Highly Improved Antiviral Activities and Favorable Druggability. Journal of Medicinal Chemistry. 64(24). 17992–18009. 15 indexed citations
14.
Du, Ruikun, et al.. (2021). Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro. Antiviral Research. 190. 105075–105075. 56 indexed citations
15.
Wang, Yanyan, Qinghua Cui, Lili Gong, et al.. (2020). Screening for Anti‐Influenza Actives of Prefractionated Traditional Chinese Medicines. Evidence-based Complementary and Alternative Medicine. 2020(1). 4979850–4979850. 8 indexed citations
16.
Du, Ruikun, Qinghua Cui, & Lijun Rong. (2020). Flu Universal Vaccines: New Tricks on an Old Virus. Virologica Sinica. 36(1). 13–24. 13 indexed citations
18.
Wang, Xu, Haiqiang Jiang, Qingtao Lv, et al.. (2019). Isolation, purification, structural analysis and biological activities of water-soluble polysaccharide from Glehniae radix. International Journal of Biological Macromolecules. 128. 724–731. 56 indexed citations
19.
Du, Ruikun, Manli Wang, Zhìhóng Hú, Huálín Wáng, & Fēi Dèng. (2015). An in vitro recombination-based reverse genetic system for rapid mutagenesis of structural genes of the Japanese encephalitis virus. Virologica Sinica. 30(5). 354–362. 2 indexed citations
20.
Jing, Yingjun, et al.. (2008). Purification and characterization of a thermal stable antimicrobial protein from housefly larvae,Musca domestica, induced by ultrasonic wave. Acta Biologica Hungarica. 59(3). 289–304. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026